why is moderna stock down today

Thursday, August 11, 2022 Edit

1 day agoWhile Moderna stock has gained about 16 since the earnings report last Wednesday it remains down by about 26 year-to-date. Shares of Moderna are down by 7 today as higher Treasury yields put significant pressure on high-growth stocks.

Is Moderna Stock A Buy Sell Or Hold After Recent Earnings Nasdaq Mrna Seeking Alpha

Analyst estimates for Modernas earnings in 2021 have recently moved lower and now analysts expect that the company will report earnings of 2931 per share this year.

. Moderna stock is already down by more than 70 from the highs that were reached back in August 2021 but there is no rush to buy the stock as traders question the. PFE stock was down 27 as of 1109 am. Shares of several top COVID-19 vaccine makers were sinking on Tuesday.

Ad 1000 Strong Buy Stocks that Double the SP. Shares of several leading COVID-19 vaccine makers were falling as of 1138 am. News that a pair of large and important customers have declined to exercise options for more Spikevax doses sent Moderna shares down by slightly more than 6 on the.

Ad Were all about helping you get more from your money. Your Long-Term Investment Goals Are Our Priority. Moderna reported revenue of 5 billion and earnings of 770.

This uncertainty helped to drive the financial markets lower in recent weeks. The decline came after the company reported that the first participant has been. Trade stocks bonds options ETFs and mutual funds all in one easy-to-manage account.

PFE stock was down 35. Why Moderna Stock Is Falling Today. Shares of Moderna gained strong downside momentum after the company released its third-quarter report.

There is a broad sell-off in the market and SP 500 is down by. There is a broad sell-off in the market and SP 500 is down by. 18 hours agoWhile Moderna stock has gained about 16 since the earnings report last Wednesday it.

Please note that all recommendations are based on our models results and do not. MRNA Moderna Stock Falls As The Company Cuts Its Full-Year Revenue Outlook Shares of Moderna gained strong downside momentum after the company released its third. Shares of BioNTech NASDAQ.

Shares of Moderna gained downside momentum after the company announced a 15-year strategic collaboration agreement with Thermo Fisher Scientific which will produce the. Analysts expect that Moderna will report earnings of 2785 in 2022 so the stock is trading at roughly 8 forward PE which is certainly cheap for the current market environment. Lets get started today.

What are analysts forecasts for Moderna stock. Shares of Moderna are down by 7 today as higher Treasury yields put significant pressure on high-growth stocks. Shares of Moderna gained downside momentum after the company announced a 15-year strategic collaboration agreement with Thermo Fisher Scientific which will produce the.

Shares of Moderna MRNA 222 were falling 47 lower as of 1155 am. The 54 analysts offering price forecasts for Moderna have a median target of 19250 with a high estimate of 46300 and a low estimate of. That wasnt the reason why Modernas.

At the current market price of 187 per share the stock is valued at. At the current market price of 187 per share the. Currently analysts expect that Moderna will report earnings of 2589 per share in 2021 and earnings of 2647 per share in 2022 so the stock is trading at roughly 9 forward PE.

Shares of Moderna NASDAQ. Amid the volatility many investors sought shelter in Moderna and other vaccine stocks on the belief. Analyst estimates for Modernas earnings in 2021 have recently moved lower and now analysts expect that the company will report earnings of 2931 per share this year.

Ad Connect With Edward Jones And Learn More About The Current Market Fluctuations. Analysts expect that Moderna will report earnings of 2785 in 2022 so the stock is trading at roughly 8 forward PE which is certainly cheap for the current market environment. MRNA were down by 53 as of 125 pm.

Mrna Moderna Inc Stock Overview U S Nasdaq Barron S